Vaxcyte, Inc. (PCVX) Operating income 2018–2025
Vaxcyte, Inc. (PCVX) annual operating income history from SEC filings — each fiscal year as reported.
-$923.7MFY2025 · since FY2018: -$35.5M → -$923.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$923.7M | -62.2% |
| FY2024 | -$569.5M | -21.7% |
| FY2023 | -$468.0M | -101.5% |
| FY2022 | -$232.3M | -124.0% |
| FY2021 | -$103.7M | -15.7% |
| FY2020 | -$89.6M | -65.4% |
| FY2019 | -$54.2M | -52.4% |
| FY2018 | -$35.5M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More PCVX financial trends
PCVX RevenuePCVX Net incomePCVX Net marginPCVX Gross profitPCVX Gross marginPCVX Operating marginPCVX Operating cash flowPCVX Free cash flowPCVX Capital expendituresPCVX Return on equityPCVX Stock buybacksPCVX Dividends paidPCVX Total assetsPCVX Total liabilitiesPCVX Shareholders’ equityPCVX overview →